Search for: "Glaxo Group Limited"
Results 21 - 40
of 49
Sorted by Relevance
|
Sort by Date
21 Sep 2010, 7:47 pm
(FDA Law Blog) US: FDA set to announce public hearing on BPCI Act implementation (FDA Law Blog) US: Precision Biosciences granted stay pending reexam of Cellectis’ patents (Patent Docs) US: Celsis granted preliminary injunction against CellzDirect in LiverPool hepatocyte treatment infringement suit (Patent Docs) US: Yeda Research and Development files suit against Abbott in District of Columbia requesting review of BPAI decision (Patent Docs) Products Angiomax (Bivalirudin) – US: The… [read post]
13 Sep 2009, 12:55 am
Shapira) indicating that court orders can override confidential information, even for financial records, and Glaxo-Wellcome PLC v. [read post]
13 Sep 2009, 1:02 am
Shapira) indicating that court orders can override confidential information, even for financial records, and Glaxo-Wellcome PLC v. [read post]
29 Feb 2024, 5:17 pm
On April 20, 2023, the PTO issued an ORDER TO SHOW CAUSE to Glaxo Group Limited (“Glaxo”) “based on the apparent ineligibility of U.S. [read post]
9 Feb 2015, 1:11 pm
Only limited data concerning the safety of [Zofran (ondansetron)] in pregnancy is available. [read post]
21 Oct 2014, 12:00 am
In Glenmark Generics (Europe) Limited & others v The Wellcome Foundation Limited & Glaxo Group Ltd, [2013] EWHC 148 (Pat), reported by the IPKat here, Arnold J decided that a combination product for treating malaria was obvious. [read post]
21 Feb 2013, 3:45 pm
Anyway, spotting a recent decision from the Patents Court, England and Wales, by the name of Glenmark Generics (Europe) Limited & others v The Wellcome Foundation Limited & and Glaxo Group Ltd [2013] EWHC 148 (Pat), his first thought was that it must have something to do with alcohol. [read post]
5 Aug 2010, 11:06 pm
Cir. 2003), and Glaxo Group Ltd. v. [read post]
15 Feb 2011, 4:06 am
Moreover, the industry has agreed upon and abides by the PhRMA Code to regulate the marketing of medicine to healthcare professionals-just as any consumer-products maker might develop rules to limit the express warranties its sales force might offer to a customer. [read post]
3 Oct 2008, 7:18 pm
., SmithKline Beecham plc, and Glaxo Group Ltd. [read post]
22 Aug 2011, 1:43 am
In Glaxo Group Ltd’s Patent [2004] RPC 43 (see also 3.30 and 3.31.1), the Patents Court held that unexpected bonus effects not described in the specification could not form the basis of a valid claim to a selection invention. [read post]
19 Mar 2015, 4:57 pm
(D.I. 537 at ¶¶ 8, 9)NADH and NADPH have distinct chemical structures, with NADPH containing an additional phosphate group. [read post]
8 Apr 2010, 5:21 pm
Glaxo had transferred ownership of the patents-in-suit to ICOS. [read post]
25 Nov 2012, 1:00 pm
Condition 5 was at issue in this case, and lucky for the court, Mr Justice Laddie had considered this condition in detail in Glaxo Group & Ors v Dowelhurst Ltd (No 2) [2000] FSR 529. [read post]
3 Jul 2012, 8:53 am
Meanwhile, this British company is running around the United States trying to pass laws to limit its liability when its drugs kill or sicken U.S. customers. [read post]
3 Jul 2012, 8:53 am
Meanwhile, this British company is running around the United States trying to pass laws to limit its liability when its drugs kill or sicken U.S. customers. [read post]
26 Jun 2007, 7:00 am
Glaxo Wellcome PLC, 246 F.3d 934, 942-43 (7th Cir. 2001).Where these laws govern, third parties have a tough time prevailing against drug and device companies on consumer fraud or deceptive trade practice claims. [read post]
27 Feb 2009, 5:00 am
USA, Inc (Orange Book Blog) (FDA Law Blog) (Patent Baristas) (Law360) (Patent Docs) (Patent Prospector) (Patently-O) (GenericsWeb) (Hal Wegner) Cipramil (Citalopram) – UK: House of Lords upholds second-generation patent that had been invalidated at first instance for insufficiency: Generics (UK) Limited and others v H Lundbeck A/S (Managing Intellectual Property)(IPKat) US: Congressman Waxman tells GPhA meeting that Hatch-Waxman model will work for follow-on biologics; draws… [read post]
13 May 2011, 2:35 pm
Cutillo previously pleaded guilty to charges related to his role in the Galleon Group insider trading scheme.Federal Judge Acquits Ex-Glaxo Lawyer Before Defense Even Starts [NPR] Ex-Ropes & Gray Associate Disbarred after Rajaratnam Verdict [Am Law Daily]Earlier: Ropes & Gray Sued for Age and Sex Discrimination By Former Partner Lawyers of the Day: Arthur Cutillo, Michael Kimelman, and Jason GoldfarbJOHN H. [read post]
6 Sep 2011, 1:10 pm
Classen states that this statute, as enacted and intended, and as judicially interpreted, is limited to activities conducted to obtain pre-marketing approval of generic counterparts of patented inventions, before patent expiration. [read post]
